Pharmaceutical News and Articles

Galderma Receives U.S. FDA Approval for Nemluvio (nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis

FDA Approves Vtama (tapinarof) Cream for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

FDA Revokes EUA for REGEN-COV (casirivimab and imdevimab) for the Treatment of COVID-19

On November 25, 2024, Regeneron requested that the U.S. Food and Drug Administration revoke the Emergency Use Authorization for REGEN-COV (Casirivimab and Imdev

FDA Revokes EUA for Sotrovimab for the Treatment of COVID-19

On November 22, 2024, GSK requested that the U.S. Food and Drug Administration revoke the Emergency Use Authorization for sotrovimab since all lots of sotrovima

FDA Revokes Emergency Use Authorization (EUA) for Bebtelovimab for the Treatment of COVID-19

On December 5, 2024, Lilly requested that the U.S. Food and Drug Administration revoke the Emergency Use Authorization for bebtelovimab since all lots of bebtel

Findings from Minzasolmin Proof-of-Concept ORCHESTRA Study Shape Next Steps in UCB Parkinson’s Research Program

UCB today announced the ORCHESTRA proof-of-concept study of minzasolmin - an investigational, oral small molecule, alpha-synuclein misfolding inhibitor - develo

Merck Provides Update on KeyVibe and KEYFORM Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations with Pembrolizumab

Merck (NYSE MRK), known as MSD outside of the United States and Canada, today announced the discontinuation of the clinical development programs for vibostolima

FDA Approves Simplified Dosing Regimen for Acetadote (N-acetylcysteine for injection)

AAP Endorses New Algorithm for Critical Congenital Heart Disease Screening

In a clinical report published online Dec. 16 in Pediatrics, the American Academy of Pediatrics endorses a new algorithm for use in critical congenital heart di

Sepsis Care Guided by Daily Procalcitonin Cuts Antibiotic Duration

Sepsis care guided by measurement of procalcitonin (PCT) reduces antibiotic duration safely compared with standard care, according to a study published online D